Loading
A US national alliance of rare cancer foundations, researchers and cancer centres building shared access to rare tumour tissue, models and data; it runs a rare cancer data pilot with Case Comprehensive Cancer Center and the Rare Cancer Research Foundation.
The Alliance for Rare Cancers states its mission as uniting the rare cancer community to speed cures for all rare cancers, and describes itself as building a coordinated national alliance to give researchers access to patient tissue, preclinical models and data. Its home page says that with Case Comprehensive Cancer Center and the Rare Cancer Research Foundation it has received a $1 million grant from the Chan Zuckerberg Initiative's Biohub for a rare cancer data pilot; Pattern.org describes the resulting Rare Cancer Data Initiative as collecting donated tumour tissue and clinical information for genome, RNA and protein studies and new research models. Its leadership page lists a board drawn from the Jedi Rare Cancer Foundation, Case Comprehensive Cancer Center, the Children's Tumor Foundation, MD Anderson, the Rare Cancer Research Foundation and others, with the head of SARC and a former executive director of NCI's MyPART on its leadership council. It is a fiscally sponsored programme of the Jedi Rare Cancer Foundation, with which it shares a post office box in Dobbs Ferry, New York.
Shares Rare Cancer Research Foundation, Rare cancers, Rare and paediatric cancers without markets.
Shares Rare Cancer Research Foundation, Rare cancers, Rare and paediatric cancers without markets.
Shares SARC (Sarcoma Alliance for Research through Collaboration), Rare Cancer Research Foundation.
Shares Pattern.org and the Pattern Biobank, Rare Cancer Research Foundation.
Shares Pattern.org and the Pattern Biobank, Rare Cancer Research Foundation.
Shares Pattern.org and the Pattern Biobank, Rare Cancer Research Foundation, Rare cancers, Rare and paediatric cancers without markets.
Shares Pattern.org and the Pattern Biobank, Rare Cancer Research Foundation.
Shares Rare cancers, Rare and paediatric cancers without markets.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/